Are you interested in helping to improve ovarian response assessment in IVF patients?

This study will determine the levels of Anti-Müllerian hormone (AMH) that are present in women undergoing in vitro fertilization (IVF). The results from this study will be used to support the development of a blood test for AMH and may aid future patients by helping to better identify women with poor ovarian response.

Who is eligible to participate?

Women between the ages of 21-46 undergoing their first IVF treatment or first egg freezing procedure are eligible to participate

What will I be asked to do?

Study participation involves one clinic visit for ultrasound and blood draw. Enrolled participants will receive $50 gift card. The ultrasound and blood draw will be done at no charge

Study Director and Researcher:
Valerie Baker, MD
REI Division
Department of OB/GYN

For more information, please contact:
Oshra Sedan, PhD CCRC
Study Coordinator

Fertility and Reproductive Health logo